(Q46677337)

24 December 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets (English)

1 reference

24 December 2017

0 references

1 reference

24 December 2017

Desiree M Schumann

0 references

Yoichiro Iwakura

0 references

Kathrin Maedler

0 references

Domenico Bosco

0 references

Claes B Wollheim

0 references

Reto Baertschiger

1 reference

24 December 2017

author name string

Nadine Sauter

1 reference

24 December 2017

Helga Ellingsgaard

1 reference

24 December 2017

José Oberholzer

1 reference

24 December 2017

Marc Y Donath

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

24 December 2017

published in

Diabetes

1 reference

24 December 2017

volume

1 reference

24 December 2017

issue

1 reference

24 December 2017

page(s)

2713-2722

1 reference

24 December 2017

Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Insulin-promoter-factor 1 is required for pancreas development in mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Mechanisms of beta-cell death in type 2 diabetes.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Type 2 diabetes-a matter of beta-cell life and death?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Adenoviral overexpression of interleukin-1 receptor antagonist protein increases beta-cell replication in rat pancreatic islets

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Cytokines cause functional and structural damage to isolated islets of Langerhans

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

The diabetes-linked transcription factor PAX4 promotes {beta}-cell proliferation and survival in rat and human islets

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Sustained proliferation of PDX-1+ cells derived from human islets

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Type II diabetes, glucose "non-sense," and islet desensitization

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

The Pax4 gene is essential for differentiation of insulin-producing β cells in the mammalian pancreas

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Islet growth and development in the adult

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

High glucose potentiates cytokine- and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genes.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1. A novel mechanism for virus-induced diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Islet secretion in a new experimental model for non-insulin-dependent diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic beta-cell destruction in insulin-dependent diabetes mellitus

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Beta-cells in type 2 diabetes: a loss of function and mass

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Molecular insights into insulin action and secretion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Islet Secretion in a New Experimental Model for Non-insulin-dependent Diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Tissue-specific and glucose-responsive expression of the pancreatic derived factor (PANDER) promoter

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DB05-1430

Identifiers

DOI

10.2337/DB05-1430

1 reference

24 December 2017

1 reference

24 December 2017